A Czech patient with Covid-19 in critical condition is being treated with Remdesivir, a drug originally developed by the US-based company Gilead Sciences to fight the Ebola virus.
A shipment of Remdesivir arrived from the US on Tuesday upon the request of Czech authorities. The Ministry of Health has approved its use on a case-by-case basis for a period of six months.
Remdesivir has shown some success in treating two viruses similar to the novel coronavirus, MERS and SARS, in animals.
The Czech patient now receiving the experimental drug, a Prague taxi driver, was admitted to the General University Hospital in critical condition and has been on ventilation for many days now.
Milan Kundera is a ‘moral relativist’ with much to hide, says Czech author of controversial new biography
Czech Republic opens up to more tourists from Europe and beyond as coronavirus travel restrictions eased
Janek Rubeš: The only question I get – and there are thousands of them – is, Can we come to Prague?
Facemask requirement eased but new restrictions for area hit by spike in Covid-19 cases
Czech nation pays tribute to Milada Horáková on 70th anniversary of her judicial murder